Harmony Outcomes

The Harmony Outcomes CVOT assessed the cardiovascular safety of albiglutide in patients with type 2 diabetes and vascular disease. This module details the study outcomes.

 

 

 

Harmony Outcomes
Rate this content
  • Harmony Outcomes
  • Harmony Outcomes
  • Harmony Outcomes
  • Harmony Outcomes: study design
  • Harmony Outcomes: primary and secondary outcomes
Do you want to go to the Presentation Builder section to create a new presentation?
Cancel Go